MTE Sessions

(Please note this programme is subject to change)

Day 1- Friday, 22 March

10:10 AM - 10:50 AM (GMT)
Meet the Experts
Keynote Session

  • KDIGO guideline updates 2024 – Paul Stevens

12:10 PM - 12:50 PM (GMT)
Meet the Experts
SGLT2i: best practices in implementation across HF, diabetes and CKD

Chair – Michel Jadoul

  • SGLT2 inhibition across T2DM, CKD and HF: evidence base and rationale for early initiation – Clara Inés Saldarriaga

  • Practical guidance for the use of SGLT2 inhibitors in patients with cardio-renal-metabolic disease – Shelley Zieroth

  • Panel Discussion


Supported by an unrestricted educational grant from AstraZeneca

2:10 PM - 2:50 PM (GMT)
Meet the Experts
Management of hyperkalemia best practices

  • The challenge of GDMT implementation in patients with heart failure and comorbidities: patient profiling and potassium management – Gianluigi Savarese

  • Optimising RAAS inhibitor therapy in patients with chronic kidney disease and comorbidities: long-term hyperkalemia management in practice – James Burton

  • Panel Discussion


Supported by an unrestricted educational grant from AstraZeneca

4:10 PM - 4:50 PM (GMT)
Meet the Experts
Optimisation of guideline-directed medical therapy in cardiorenal patients: overcoming the barrier of hyperkalemia

ChairIleana Piña

  • Guideline-directed medical therapy in cardiorenal patients: advances and implementation gaps – Iris Beldhuis

  • Long-term hyperkalemia management in cardiorenal patients: potassium binders as enabling therapy – David Wheeler

  • Panel Discussion


Supported by an unrestricted educational grant from CSL Vifor

8:10 PM - 8:50 PM (GMT)
Meet the Experts
Replay of Keynote Session

  • KDIGO guideline updates 2024 – Paul Stevens


Day 2 - Saturday, 23 March

10:10 AM - 10:50 AM (GMT)
Meet the Experts
Practical implementation of non-steroidal mineralocorticoid receptor antagonists to reduce cardiorenal risk

Muthiah Vaduganathan & David Charytan

4:10 PM - 4:50 PM (GMT)
Meet the Experts
Effects of GLP- 1RA on kidney outcomes in CKD and T2D

Stefan Anker & Peter Rossing




If you’re interested in becoming an educational partner or sponsor at this event, please contact


KDIGO is a global organisation developing and implementing evidence-based clinical practice guidelines in kidney disease. It is an independent, volunteer-led, self-managed foundation incorporated in Belgium and accountable to the public and the patients it serves.

KDIGO’s mission is to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines.

For more information on KDIGO, please visit

About Translational Medicine Academy

Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.

Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.

For more information on TMA, please visit

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking

Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit